Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Universe Pharmaceuticals (UPC) Inventory (2021 - 2025)

Universe Pharmaceuticals' Inventory history spans 5 years, with the latest figure at $2.2 billion for Q3 2025.

  • For Q3 2025, Inventory rose 126158.54% year-over-year to $2.2 billion; the TTM value through Sep 2025 reached $2.2 billion, up 126158.54%, while the annual FY2025 figure was $2.2 billion, 126158.54% up from the prior year.
  • Inventory for Q3 2025 was $2.2 billion at Universe Pharmaceuticals, up from $1.7 million in the prior quarter.
  • Across five years, Inventory topped out at $2.2 billion in Q3 2025 and bottomed at $180643.0 in Q3 2023.
  • The 5-year median for Inventory is $2.2 million (2022), against an average of $440.0 million.
  • The largest annual shift saw Inventory tumbled 91.81% in 2023 before it surged 126158.54% in 2025.
  • A 5-year view of Inventory shows it stood at $2.5 million in 2021, then fell by 10.4% to $2.2 million in 2022, then crashed by 91.81% to $180643.0 in 2023, then surged by 861.59% to $1.7 million in 2024, then soared by 126158.54% to $2.2 billion in 2025.
  • Per Business Quant, the three most recent readings for UPC's Inventory are $2.2 billion (Q3 2025), $1.7 million (Q3 2024), and $180643.0 (Q3 2023).